Clinical Trial Update: Phase II Study of 5-azacytidine Maintenance After Transplant for AML or MDS [Phase 2]

View source ↗

Summary

A Phase II study evaluating maintenance therapy with 5-azacitidine after stem cell transplant in acute myeloid leukemia or myelodysplastic syndromes has been wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• 5-Azacytidine (5-azacytidine)

Snippet

Sponsor: University of Pittsburgh | Conditions: Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS) | Phase 2 | Status: WITHDRAWN